We previously proved that the blockade of other typical chemokine receptors, such as CCR1 by J113863 (21), CCR2 by RS504393 (22) and CCR5 by maraviroc (69), enhanced the analgesic properties of morphine and buprenorphine under neuropathy. The gene discussed is CCR2; the disease is neuropathy.